Gene Symbol | Gene ID | Gene Info |
---|---|---|
Stat1
|
ENSMUSG00000026104.8 | signal transducer and activator of transcription 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_52146661_52146873 | Stat1 | 3337 | 0.175646 | -0.72 | 7.1e-10 | Click! |
chr1_52119062_52120033 | Stat1 | 2 | 0.963756 | 0.39 | 3.5e-03 | Click! |
chr1_52158937_52159103 | Stat1 | 6767 | 0.150053 | 0.34 | 1.0e-02 | Click! |
chr1_52150701_52150994 | Stat1 | 589 | 0.672351 | 0.32 | 1.7e-02 | Click! |
chr1_52154927_52155094 | Stat1 | 2757 | 0.202380 | -0.28 | 3.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_58648523_58648684 | 34.90 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
8021 |
0.23 |
chr7_80542454_80542814 | 27.98 |
Blm |
Bloom syndrome, RecQ like helicase |
7515 |
0.17 |
chr11_80872544_80872855 | 23.40 |
Spaca3 |
sperm acrosome associated 3 |
14327 |
0.18 |
chr16_20703749_20704029 | 18.75 |
Clcn2 |
chloride channel, voltage-sensitive 2 |
4845 |
0.08 |
chr11_87368253_87368600 | 18.41 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
9403 |
0.12 |
chr4_128669269_128669559 | 18.26 |
Phc2 |
polyhomeotic 2 |
14676 |
0.17 |
chr5_100636931_100637107 | 17.96 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
27400 |
0.12 |
chr10_41205578_41205924 | 16.90 |
Gm25526 |
predicted gene, 25526 |
10294 |
0.2 |
chr16_58661948_58662241 | 16.31 |
Gm49701 |
predicted gene, 49701 |
6850 |
0.13 |
chr16_49775686_49775907 | 16.18 |
Gm15518 |
predicted gene 15518 |
23074 |
0.2 |
chr5_118480054_118480344 | 15.86 |
Gm15754 |
predicted gene 15754 |
6768 |
0.21 |
chr1_73036588_73036920 | 15.83 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
12185 |
0.22 |
chr8_91872955_91873134 | 15.80 |
Gm28511 |
predicted gene 28511 |
7173 |
0.18 |
chr14_70336335_70336839 | 14.95 |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
2389 |
0.19 |
chr11_58214634_58215080 | 14.75 |
Irgm2 |
immunity-related GTPase family M member 2 |
151 |
0.92 |
chr1_37478554_37478868 | 14.46 |
4930594C11Rik |
RIKEN cDNA 4930594C11 gene |
9894 |
0.14 |
chr3_95674303_95674509 | 14.43 |
Adamtsl4 |
ADAMTS-like 4 |
2745 |
0.15 |
chr15_9463563_9463744 | 14.37 |
Gm50456 |
predicted gene, 50456 |
11849 |
0.2 |
chr1_171452961_171453272 | 14.36 |
F11r |
F11 receptor |
9734 |
0.09 |
chr16_22899979_22900147 | 14.35 |
Ahsg |
alpha-2-HS-glycoprotein |
5199 |
0.13 |
chr3_88509686_88510447 | 14.31 |
Lmna |
lamin A |
110 |
0.91 |
chr2_167431474_167431671 | 14.14 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
7453 |
0.18 |
chr5_146703717_146704190 | 13.96 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
2669 |
0.26 |
chr4_136214630_136214793 | 13.95 |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
8346 |
0.15 |
chr9_107312801_107313233 | 13.83 |
Gm17041 |
predicted gene 17041 |
11179 |
0.09 |
chr14_41105245_41105442 | 13.79 |
Mat1a |
methionine adenosyltransferase I, alpha |
38 |
0.96 |
chr7_144786613_144786803 | 13.55 |
Gm34964 |
predicted gene, 34964 |
5100 |
0.12 |
chr3_10243757_10243938 | 13.55 |
1700029B24Rik |
RIKEN cDNA 1700029B24 gene |
2035 |
0.18 |
chr3_66563505_66563681 | 13.28 |
Gm17952 |
predicted gene, 17952 |
42 |
0.99 |
chr16_35905930_35906086 | 13.03 |
Gm10237 |
predicted gene 10237 |
14456 |
0.1 |
chr11_57952722_57952903 | 12.96 |
Gm12245 |
predicted gene 12245 |
3727 |
0.2 |
chr1_77281437_77282151 | 12.94 |
Epha4 |
Eph receptor A4 |
95813 |
0.08 |
chr15_86064933_86065094 | 12.75 |
Gramd4 |
GRAM domain containing 4 |
2800 |
0.25 |
chr5_143058786_143058991 | 12.74 |
Gm43380 |
predicted gene 43380 |
8765 |
0.14 |
chr3_84772307_84772458 | 12.52 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
42886 |
0.17 |
chr1_185420949_185421102 | 12.51 |
AC131980.1 |
solute carrier family 30, member 10 (Slc30a10) pseudogene |
10988 |
0.11 |
chr4_148084250_148084566 | 12.51 |
Agtrap |
angiotensin II, type I receptor-associated protein |
368 |
0.75 |
chr4_132060491_132060796 | 12.39 |
Epb41 |
erythrocyte membrane protein band 4.1 |
11454 |
0.11 |
chr7_97210129_97210318 | 12.19 |
Usp35 |
ubiquitin specific peptidase 35 |
104802 |
0.06 |
chr4_48160493_48160644 | 11.78 |
Stx17 |
syntaxin 17 |
35633 |
0.15 |
chr15_53200097_53200256 | 11.58 |
Ext1 |
exostosin glycosyltransferase 1 |
3921 |
0.37 |
chrX_143044306_143044632 | 11.55 |
Rtl9 |
retrotransposon Gag like 9 |
55125 |
0.13 |
chr5_3439078_3439369 | 11.54 |
Cdk6 |
cyclin-dependent kinase 6 |
31726 |
0.13 |
chr2_60269924_60270087 | 11.43 |
Rpl10a-ps4 |
ribosomal protein L10A, pseudogene 4 |
5569 |
0.17 |
chr5_64811569_64811963 | 11.41 |
Klf3 |
Kruppel-like factor 3 (basic) |
573 |
0.7 |
chr5_96951661_96952003 | 11.37 |
Gm43144 |
predicted gene 43144 |
11535 |
0.1 |
chr7_66197335_66197562 | 11.25 |
Gm45080 |
predicted gene 45080 |
6893 |
0.17 |
chr11_31843822_31844223 | 11.23 |
Gm12107 |
predicted gene 12107 |
11362 |
0.18 |
chr15_62229582_62229849 | 11.16 |
Pvt1 |
Pvt1 oncogene |
7112 |
0.25 |
chr1_133797348_133797649 | 11.07 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
3538 |
0.18 |
chr4_130181960_130182111 | 11.02 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
6913 |
0.17 |
chr1_133951696_133951957 | 10.98 |
Gm1627 |
predicted gene 1627 |
10336 |
0.15 |
chr13_58477313_58477467 | 10.88 |
Gm47918 |
predicted gene, 47918 |
34369 |
0.13 |
chr1_155408109_155408274 | 10.83 |
Xpr1 |
xenotropic and polytropic retrovirus receptor 1 |
9138 |
0.25 |
chr17_56609730_56610422 | 10.82 |
Micos13 |
mitochondrial contact site and cristae organizing system subunit 13 |
305 |
0.8 |
chr16_93365247_93365596 | 10.82 |
1810053B23Rik |
RIKEN cDNA 1810053B23 gene |
31 |
0.97 |
chr8_11140606_11140895 | 10.81 |
Gm44717 |
predicted gene 44717 |
8496 |
0.16 |
chr10_75837063_75837779 | 10.78 |
Gstt2 |
glutathione S-transferase, theta 2 |
3 |
0.95 |
chr11_88996503_88996757 | 10.60 |
Gm11496 |
predicted gene 11496 |
86 |
0.94 |
chr6_88152237_88152433 | 10.59 |
Gm38708 |
predicted gene, 38708 |
38346 |
0.09 |
chr13_93388637_93389177 | 10.49 |
Gm47155 |
predicted gene, 47155 |
21876 |
0.14 |
chr12_80079920_80080101 | 10.48 |
Gm36660 |
predicted gene, 36660 |
1424 |
0.34 |
chr2_156924238_156924504 | 10.44 |
Gm14278 |
predicted gene 14278 |
8988 |
0.1 |
chr17_74267170_74267341 | 10.29 |
Memo1 |
mediator of cell motility 1 |
11270 |
0.14 |
chr1_82832529_82832680 | 10.29 |
Gm22396 |
predicted gene, 22396 |
6842 |
0.1 |
chr5_148897060_148897772 | 10.26 |
Katnal1 |
katanin p60 subunit A-like 1 |
18337 |
0.11 |
chr9_35200573_35200794 | 10.26 |
Tirap |
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein |
392 |
0.51 |
chr17_45885570_45885733 | 10.17 |
Gm41584 |
predicted gene, 41584 |
305 |
0.88 |
chr4_115059412_115059621 | 10.04 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
8 |
0.97 |
chr7_103865311_103865713 | 10.01 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12296 |
0.06 |
chr17_34836344_34837687 | 9.85 |
Dxo |
decapping exoribonuclease |
4 |
0.52 |
chr2_118659301_118659477 | 9.79 |
Pak6 |
p21 (RAC1) activated kinase 6 |
3914 |
0.18 |
chr5_135951162_135951333 | 9.73 |
Ssc4d |
scavenger receptor cysteine rich family, 4 domains |
11024 |
0.11 |
chr8_77044570_77044721 | 9.70 |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
83368 |
0.09 |
chr10_93679260_93679437 | 9.69 |
Gm15915 |
predicted gene 15915 |
3974 |
0.17 |
chr1_9584780_9584933 | 9.68 |
Gm6161 |
predicted gene 6161 |
10308 |
0.13 |
chr1_131638169_131638320 | 9.68 |
Ctse |
cathepsin E |
62 |
0.97 |
chr3_94693694_94693864 | 9.67 |
Selenbp2 |
selenium binding protein 2 |
120 |
0.93 |
chr9_70922223_70922596 | 9.67 |
Gm32017 |
predicted gene, 32017 |
8079 |
0.21 |
chr6_83312515_83312842 | 9.60 |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
273 |
0.85 |
chr17_57232874_57233113 | 9.55 |
C3 |
complement component 3 |
4857 |
0.12 |
chr17_57230825_57231190 | 9.38 |
C3 |
complement component 3 |
2871 |
0.15 |
chr12_30943684_30943877 | 9.37 |
Sh3yl1 |
Sh3 domain YSC-like 1 |
31593 |
0.13 |
chr7_17059591_17061170 | 9.36 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1846 |
0.19 |
chr16_93816332_93816772 | 9.32 |
Dop1b |
DOP1 leucine zipper like protein B |
7118 |
0.14 |
chr7_106651998_106652182 | 9.17 |
Olfr693 |
olfactory receptor 693 |
26395 |
0.11 |
chr15_98827590_98827953 | 9.16 |
Prkag1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
1643 |
0.18 |
chr11_115841930_115842217 | 9.13 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
7750 |
0.1 |
chr11_58199487_58199685 | 9.03 |
Igtp |
interferon gamma induced GTPase |
0 |
0.5 |
chr7_109636438_109636727 | 9.03 |
Denn2b |
DENN domain containing 2B |
19435 |
0.15 |
chr8_69127207_69127379 | 8.90 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
13660 |
0.16 |
chr6_138141403_138141730 | 8.89 |
Mgst1 |
microsomal glutathione S-transferase 1 |
20 |
0.99 |
chr5_57760763_57760931 | 8.87 |
Gm42481 |
predicted gene 42481 |
18026 |
0.12 |
chr10_125933532_125933683 | 8.86 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
32561 |
0.23 |
chr17_45742753_45743077 | 8.86 |
F630040K05Rik |
RIKEN cDNA F630040K05 gene |
8409 |
0.14 |
chr16_90779617_90779768 | 8.82 |
Urb1 |
URB1 ribosome biogenesis 1 homolog (S. cerevisiae) |
6901 |
0.16 |
chr19_43797245_43797399 | 8.79 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
664 |
0.65 |
chr18_37932934_37933379 | 8.79 |
Diaph1 |
diaphanous related formin 1 |
2225 |
0.15 |
chr2_26037240_26037751 | 8.72 |
Ubac1 |
ubiquitin associated domain containing 1 |
15748 |
0.12 |
chr9_110699835_110699986 | 8.72 |
Ccdc12 |
coiled-coil domain containing 12 |
9984 |
0.11 |
chr6_34716974_34717133 | 8.72 |
Cald1 |
caldesmon 1 |
7419 |
0.14 |
chr5_100567324_100567596 | 8.67 |
Plac8 |
placenta-specific 8 |
4037 |
0.16 |
chr15_62158872_62159049 | 8.63 |
Pvt1 |
Pvt1 oncogene |
19215 |
0.25 |
chr16_32510996_32511218 | 8.60 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
11496 |
0.13 |
chr15_81891199_81891462 | 8.59 |
Aco2 |
aconitase 2, mitochondrial |
3976 |
0.11 |
chr13_8849347_8849637 | 8.57 |
Wdr37 |
WD repeat domain 37 |
66 |
0.95 |
chr11_120354046_120354234 | 8.55 |
0610009L18Rik |
RIKEN cDNA 0610009L18 gene |
5462 |
0.08 |
chr11_50197609_50197760 | 8.54 |
Sqstm1 |
sequestosome 1 |
5270 |
0.12 |
chr1_36919717_36920078 | 8.52 |
Gm38115 |
predicted gene, 38115 |
3358 |
0.17 |
chr19_37009838_37010018 | 8.49 |
Btaf1 |
B-TFIID TATA-box binding protein associated factor 1 |
48613 |
0.14 |
chr7_103812071_103812255 | 8.44 |
Hbb-bt |
hemoglobin, beta adult t chain |
1833 |
0.13 |
chr3_84413876_84414216 | 8.42 |
4930565D16Rik |
RIKEN cDNA 4930565D16 gene |
34125 |
0.17 |
chr4_150588390_150588541 | 8.41 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
18808 |
0.18 |
chr2_156991546_156992589 | 8.35 |
Ndrg3 |
N-myc downstream regulated gene 3 |
11 |
0.96 |
chr13_74282351_74282596 | 8.33 |
Ahrr |
aryl-hydrocarbon receptor repressor |
9824 |
0.13 |
chr15_36688365_36688735 | 8.28 |
Gm10385 |
predicted gene 10385 |
1553 |
0.31 |
chr18_10038202_10038371 | 8.26 |
Usp14 |
ubiquitin specific peptidase 14 |
6819 |
0.18 |
chrX_163746038_163746338 | 8.22 |
Rnf138rt1 |
ring finger protein 138, retrogene 1 |
15141 |
0.23 |
chr4_109317382_109317533 | 8.20 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
8306 |
0.21 |
chr1_51720415_51720582 | 8.07 |
Gm28055 |
predicted gene 28055 |
22598 |
0.19 |
chr2_27560675_27560886 | 7.99 |
Gm13421 |
predicted gene 13421 |
20351 |
0.14 |
chr18_42510920_42511513 | 7.99 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr18_50031236_50031404 | 7.98 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
291 |
0.92 |
chr2_35616967_35617243 | 7.97 |
Dab2ip |
disabled 2 interacting protein |
4876 |
0.24 |
chr7_35090664_35090828 | 7.96 |
Gm35611 |
predicted gene, 35611 |
3910 |
0.1 |
chr9_60262599_60262779 | 7.92 |
2010001M07Rik |
RIKEN cDNA 2010001M07 gene |
71453 |
0.1 |
chr7_51851013_51851172 | 7.87 |
Gm45001 |
predicted gene 45001 |
788 |
0.56 |
chr10_7275610_7275761 | 7.85 |
Cnksr3 |
Cnksr family member 3 |
63448 |
0.13 |
chr2_146099017_146099372 | 7.83 |
Cfap61 |
cilia and flagella associated protein 61 |
51943 |
0.15 |
chr2_119727856_119728024 | 7.83 |
Rtf1 |
RTF1, Paf1/RNA polymerase II complex component |
1256 |
0.31 |
chr15_103260111_103260328 | 7.82 |
Nfe2 |
nuclear factor, erythroid derived 2 |
1816 |
0.2 |
chr17_71235938_71236335 | 7.77 |
Lpin2 |
lipin 2 |
2526 |
0.24 |
chr8_109614580_109614731 | 7.71 |
Pkd1l3 |
polycystic kidney disease 1 like 3 |
47 |
0.97 |
chr8_110933315_110933782 | 7.70 |
St3gal2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
1627 |
0.24 |
chr6_55324727_55325118 | 7.62 |
Aqp1 |
aquaporin 1 |
11510 |
0.14 |
chr5_30617970_30618148 | 7.62 |
Kcnk3 |
potassium channel, subfamily K, member 3 |
3314 |
0.17 |
chr3_51157400_51157558 | 7.61 |
Gm38246 |
predicted gene, 38246 |
53819 |
0.1 |
chr1_13467275_13467461 | 7.61 |
Gm7593 |
predicted gene 7593 |
59713 |
0.1 |
chr17_28438853_28439023 | 7.60 |
Fkbp5 |
FK506 binding protein 5 |
2072 |
0.18 |
chr19_24528181_24528407 | 7.54 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
27495 |
0.16 |
chr11_102143068_102143252 | 7.53 |
Nags |
N-acetylglutamate synthase |
2353 |
0.13 |
chr1_180148615_180148897 | 7.53 |
Gm38331 |
predicted gene, 38331 |
605 |
0.7 |
chr3_132479396_132479547 | 7.51 |
Gm42880 |
predicted gene 42880 |
33923 |
0.19 |
chr15_99449170_99449742 | 7.47 |
Nckap5l |
NCK-associated protein 5-like |
8256 |
0.1 |
chr15_83223251_83223918 | 7.44 |
A4galt |
alpha 1,4-galactosyltransferase |
28145 |
0.1 |
chr1_191956917_191957212 | 7.42 |
Rd3 |
retinal degeneration 3 |
20306 |
0.11 |
chr12_11265672_11266639 | 7.41 |
Smc6 |
structural maintenance of chromosomes 6 |
14 |
0.85 |
chr9_44515403_44515586 | 7.40 |
Cxcr5 |
chemokine (C-X-C motif) receptor 5 |
10927 |
0.07 |
chr1_155794943_155795211 | 7.36 |
Qsox1 |
quiescin Q6 sulfhydryl oxidase 1 |
340 |
0.82 |
chr19_24535123_24535505 | 7.36 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
20475 |
0.18 |
chr7_125471990_125472772 | 7.35 |
Nsmce1 |
NSE1 homolog, SMC5-SMC6 complex component |
6178 |
0.18 |
chr6_70903772_70904042 | 7.29 |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
7143 |
0.15 |
chr10_97877200_97877351 | 7.27 |
Gm10754 |
predicted gene 10754 |
89815 |
0.08 |
chr15_93518893_93519702 | 7.26 |
Prickle1 |
prickle planar cell polarity protein 1 |
226 |
0.95 |
chr16_93197370_93197689 | 7.20 |
Gm28003 |
predicted gene, 28003 |
124774 |
0.05 |
chr2_170205605_170205766 | 7.19 |
Zfp217 |
zinc finger protein 217 |
57582 |
0.13 |
chr9_107296490_107296947 | 7.10 |
Cish |
cytokine inducible SH2-containing protein |
8 |
0.88 |
chr2_167671373_167671565 | 7.08 |
Gm14320 |
predicted gene 14320 |
9360 |
0.1 |
chr4_40852360_40852761 | 7.07 |
B4galt1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
1445 |
0.23 |
chr18_56973951_56974146 | 7.00 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
1198 |
0.53 |
chr7_119251734_119252076 | 7.00 |
Gm4083 |
predicted gene 4083 |
49802 |
0.12 |
chr11_5499263_5499558 | 6.97 |
Gm11963 |
predicted gene 11963 |
570 |
0.67 |
chr4_115088603_115088783 | 6.97 |
Pdzk1ip1 |
PDZK1 interacting protein 1 |
15 |
0.97 |
chr5_36315209_36315379 | 6.93 |
Mir7689 |
microRNA 7689 |
13724 |
0.21 |
chr11_21240216_21240367 | 6.92 |
Vps54 |
VPS54 GARP complex subunit |
1010 |
0.43 |
chr8_124569694_124570048 | 6.89 |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
165 |
0.95 |
chr11_59885300_59885570 | 6.80 |
Gm12714 |
predicted gene 12714 |
12939 |
0.11 |
chr1_178597888_178598039 | 6.80 |
Gm24405 |
predicted gene, 24405 |
38942 |
0.17 |
chr4_115839980_115840187 | 6.79 |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
823 |
0.5 |
chr6_51546214_51546365 | 6.79 |
Snx10 |
sorting nexin 10 |
1723 |
0.4 |
chr2_169351573_169351724 | 6.78 |
Gm14250 |
predicted gene 14250 |
37433 |
0.17 |
chr1_126515477_126515628 | 6.78 |
Nckap5 |
NCK-associated protein 5 |
22625 |
0.28 |
chr14_55713469_55713678 | 6.77 |
Tgm1 |
transglutaminase 1, K polypeptide |
79 |
0.91 |
chr14_75178918_75179170 | 6.77 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2836 |
0.22 |
chr7_63999241_63999848 | 6.75 |
Gm32633 |
predicted gene, 32633 |
2341 |
0.24 |
chr2_38536332_38536674 | 6.73 |
Gm35808 |
predicted gene, 35808 |
796 |
0.52 |
chr11_98682186_98682721 | 6.70 |
Psmd3 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 |
101 |
0.9 |
chr12_59040473_59040783 | 6.69 |
Gm22973 |
predicted gene, 22973 |
293 |
0.83 |
chr11_4095576_4095728 | 6.67 |
Mtfp1 |
mitochondrial fission process 1 |
207 |
0.87 |
chr17_83057926_83058089 | 6.63 |
Gm29052 |
predicted gene 29052 |
10898 |
0.21 |
chr11_53519330_53520879 | 6.63 |
Septin8 |
septin 8 |
177 |
0.9 |
chr10_112954248_112954399 | 6.63 |
Gm47519 |
predicted gene, 47519 |
5865 |
0.18 |
chr14_66280591_66280781 | 6.63 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
296 |
0.89 |
chr2_119156064_119156242 | 6.63 |
Rmdn3 |
regulator of microtubule dynamics 3 |
671 |
0.53 |
chr2_38926098_38926539 | 6.62 |
Nr6a1 |
nuclear receptor subfamily 6, group A, member 1 |
43 |
0.95 |
chr11_4984880_4985031 | 6.60 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
1869 |
0.26 |
chr11_116533356_116533701 | 6.59 |
Sphk1 |
sphingosine kinase 1 |
47 |
0.86 |
chr9_70421744_70422098 | 6.56 |
Ccnb2 |
cyclin B2 |
374 |
0.84 |
chr10_80422148_80422431 | 6.55 |
Tcf3 |
transcription factor 3 |
429 |
0.65 |
chr19_32202196_32202495 | 6.54 |
Sgms1 |
sphingomyelin synthase 1 |
5917 |
0.23 |
chr9_21015872_21016064 | 6.52 |
Icam1 |
intercellular adhesion molecule 1 |
17 |
0.93 |
chr10_40349107_40350122 | 6.51 |
Cdk19 |
cyclin-dependent kinase 19 |
88 |
0.86 |
chr17_33498930_33499218 | 6.50 |
Adamts10 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 10 |
25130 |
0.12 |
chrX_150549714_150550031 | 6.45 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
2413 |
0.21 |
chr7_12949419_12949833 | 6.38 |
1810019N24Rik |
RIKEN cDNA 1810019N24 gene |
440 |
0.63 |
chr5_100643409_100643562 | 6.38 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
20934 |
0.13 |
chr1_171674544_171674724 | 6.34 |
Gm37981 |
predicted gene, 37981 |
5236 |
0.09 |
chr7_138918949_138919944 | 6.33 |
Gm9358 |
predicted gene 9358 |
5058 |
0.13 |
chr3_83025861_83026012 | 6.33 |
Fga |
fibrinogen alpha chain |
140 |
0.94 |
chr3_131364539_131364999 | 6.29 |
Gm43116 |
predicted gene 43116 |
4213 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
4.4 | 13.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
3.3 | 9.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.2 | 9.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.9 | 8.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.0 | 6.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.0 | 5.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.9 | 5.8 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.9 | 7.7 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.9 | 5.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.9 | 5.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.7 | 8.3 | GO:0046618 | drug export(GO:0046618) |
1.6 | 6.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.5 | 7.7 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.5 | 7.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.5 | 4.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.5 | 4.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.5 | 4.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.5 | 7.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.4 | 5.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.4 | 5.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.3 | 4.0 | GO:0003032 | detection of oxygen(GO:0003032) |
1.3 | 5.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
1.2 | 3.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.2 | 3.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.1 | 4.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.1 | 3.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
1.1 | 6.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.1 | 3.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.1 | 3.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.1 | 3.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.1 | 3.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.0 | 6.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.0 | 5.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.0 | 4.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
1.0 | 3.0 | GO:0008228 | opsonization(GO:0008228) |
1.0 | 4.0 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
1.0 | 3.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.0 | 3.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.9 | 2.8 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.9 | 10.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.9 | 1.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.9 | 1.9 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.9 | 1.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.9 | 4.6 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.9 | 3.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.9 | 3.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.9 | 7.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.9 | 5.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.9 | 3.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.9 | 5.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.9 | 3.5 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.9 | 1.7 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.9 | 3.4 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.8 | 2.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.8 | 3.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.8 | 8.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.8 | 2.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.8 | 3.9 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.8 | 2.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.8 | 0.8 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.8 | 3.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.7 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.7 | 3.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 2.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 3.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.7 | 4.5 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.7 | 2.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 3.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.7 | 8.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.7 | 7.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.7 | 0.7 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.7 | 3.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.7 | 2.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.7 | 2.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.7 | 2.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 20.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 4.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.7 | 4.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.7 | 2.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 2.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 0.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.6 | 1.9 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 6.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.6 | 1.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.6 | 1.2 | GO:0061724 | lipophagy(GO:0061724) |
0.6 | 1.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.6 | 2.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.6 | 9.9 | GO:0050779 | RNA destabilization(GO:0050779) |
0.6 | 1.7 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.6 | 3.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.6 | 2.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 1.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.6 | 1.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.6 | 3.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.6 | 2.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.5 | 2.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 2.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.5 | 2.7 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.5 | 1.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.5 | 2.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 5.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 2.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 2.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.5 | 1.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.5 | 1.6 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.5 | 1.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 3.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.5 | 1.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.5 | 3.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 1.6 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.5 | 1.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.5 | 1.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 1.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 2.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 7.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.5 | 6.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.5 | 2.9 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.5 | 1.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.5 | 1.9 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.5 | 1.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 2.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 3.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 1.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.5 | 2.8 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.5 | 5.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.5 | 1.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.5 | 3.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.5 | 5.0 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.5 | 2.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.5 | 0.9 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.5 | 2.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 0.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 1.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 1.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 3.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.4 | 1.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 3.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 0.8 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.4 | 0.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 2.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.4 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 2.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 1.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 2.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 2.9 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.4 | 1.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 2.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 2.0 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 2.0 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.4 | 0.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.4 | 1.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.4 | 2.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.4 | 2.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.4 | 1.2 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 2.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 0.4 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.4 | 1.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 4.2 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.4 | 1.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 1.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 2.2 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.4 | 2.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 4.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 5.6 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.4 | 1.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 1.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.4 | 1.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.4 | 1.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 0.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 0.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.4 | 1.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 7.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 8.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 8.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.4 | 0.7 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.4 | 0.4 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.4 | 1.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 0.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.3 | 0.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 0.7 | GO:0043489 | RNA stabilization(GO:0043489) |
0.3 | 0.7 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.3 | 1.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 1.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 1.0 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 3.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 1.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 1.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 1.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 11.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 6.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.3 | 3.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 2.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 0.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 1.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 1.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 1.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 2.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.3 | 3.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.3 | 4.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 1.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 0.3 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.3 | 2.9 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.3 | 0.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 0.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.3 | 1.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 1.9 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 3.8 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 5.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.3 | 1.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 4.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 1.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 0.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 2.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 4.0 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.3 | 0.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 1.5 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 1.2 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.9 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.3 | 0.3 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.3 | 1.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 3.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 1.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 1.2 | GO:0097286 | iron ion import(GO:0097286) |
0.3 | 3.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 2.1 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.3 | 1.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 3.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 2.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 1.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.3 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.3 | 0.3 | GO:1902965 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.3 | 2.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 4.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 1.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.3 | 0.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 0.6 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.3 | 1.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.3 | 2.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 2.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 0.3 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.3 | GO:0046385 | dTTP biosynthetic process(GO:0006235) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) 2'-deoxyribonucleotide biosynthetic process(GO:0009265) dTTP metabolic process(GO:0046075) deoxyribose phosphate biosynthetic process(GO:0046385) |
0.3 | 2.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 0.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 0.5 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 1.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 4.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 2.9 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 1.6 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.3 | 5.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 2.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.3 | 1.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.3 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 8.7 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.3 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 1.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 0.5 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 2.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.2 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.2 | 0.2 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.2 | 2.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 2.0 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.2 | 1.7 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 2.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 1.0 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 0.7 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 0.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 1.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 6.7 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.7 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 1.9 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 1.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.2 | 0.9 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.2 | 2.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 2.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 1.1 | GO:0006548 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 8.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 2.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 1.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.2 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.2 | 0.5 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.2 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 1.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 2.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.2 | 1.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 2.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 1.9 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 0.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 0.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 1.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 0.8 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.8 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.2 | 0.6 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 3.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.2 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.2 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.2 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.2 | 0.8 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 1.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 0.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 2.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 2.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 1.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 1.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 1.2 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.2 | 1.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.8 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 1.0 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 1.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.6 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.2 | 0.4 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.2 | 2.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 5.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.6 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 2.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.6 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 1.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.2 | 1.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.6 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.2 | 1.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.6 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.2 | 2.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 0.6 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 0.8 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.2 | 1.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.6 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 1.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.4 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.2 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 2.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.6 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 1.5 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 1.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.8 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 5.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.2 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 1.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 2.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 2.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.2 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 0.5 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.2 | 0.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.2 | 0.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 0.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 1.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 1.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 1.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 0.7 | GO:0060430 | lung saccule development(GO:0060430) |
0.2 | 2.6 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.2 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 1.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 2.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.2 | 3.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 0.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 1.9 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 2.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 1.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 4.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 3.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 5.0 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.8 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 1.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 0.2 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.2 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.2 | 0.8 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.5 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.2 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.2 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 1.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 1.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 1.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.4 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 1.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 1.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.6 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 1.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 2.1 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.4 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.3 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.1 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 1.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 2.6 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.7 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 1.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.7 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.8 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 4.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 1.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.4 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 5.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 1.6 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 1.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.4 | GO:0006534 | cysteine metabolic process(GO:0006534) homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.1 | 1.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.6 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 1.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.6 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.1 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.1 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.1 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.5 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 4.1 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 1.9 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.0 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 4.4 | GO:0031638 | zymogen activation(GO:0031638) |
0.1 | 1.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 1.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 1.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.1 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 1.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 1.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 1.9 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.4 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 1.4 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 1.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.7 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 2.1 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 1.6 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.1 | 0.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.8 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.9 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 1.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.2 | GO:0033132 | regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 1.8 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.7 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 3.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.9 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.5 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 1.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.3 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 1.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.7 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 0.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.6 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.6 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.1 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.1 | 1.9 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.4 | GO:0032048 | cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.2 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 1.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 1.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.6 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.3 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.4 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 1.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 1.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.3 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 1.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.8 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.4 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.7 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.2 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.1 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 1.2 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.8 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.1 | 0.2 | GO:0007418 | ventral midline development(GO:0007418) |
0.1 | 0.4 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 1.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.1 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.1 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.1 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 1.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.2 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 2.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 3.8 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
0.1 | 0.6 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 3.1 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.4 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.2 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.9 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.1 | 0.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.4 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.2 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.9 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.9 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 1.0 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 2.1 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.4 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 1.7 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.1 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 3.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 1.8 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.8 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.3 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.1 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.1 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.1 | 0.6 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 1.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 1.3 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.1 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.1 | 0.1 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 2.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.1 | 1.7 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.1 | GO:2000138 | positive regulation of sarcomere organization(GO:0060298) positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.3 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.5 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.2 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.1 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.1 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 0.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.4 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.7 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.2 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.3 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 1.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 1.5 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.1 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.4 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.5 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.5 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.2 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.0 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.0 | GO:0033483 | gas homeostasis(GO:0033483) |
0.0 | 0.0 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) |
0.0 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.3 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.3 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.2 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.0 | 0.1 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.0 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.8 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 2.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.1 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.0 | 0.0 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.0 | 0.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 1.0 | GO:0071466 | xenobiotic metabolic process(GO:0006805) cellular response to xenobiotic stimulus(GO:0071466) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.3 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 1.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 3.1 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 1.1 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.2 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0070384 | Harderian gland development(GO:0070384) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.4 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.0 | 0.1 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
0.0 | 0.2 | GO:0019068 | virion assembly(GO:0019068) |
0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.1 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.0 | 0.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.0 | 0.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.5 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.4 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.0 | 0.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.0 | 0.1 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.0 | 0.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.0 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.0 | 0.0 | GO:0002524 | hypersensitivity(GO:0002524) |
0.0 | 0.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.3 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.4 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.3 | GO:0017145 | stem cell division(GO:0017145) |
0.0 | 0.1 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.1 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.1 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.0 | 0.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.1 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:2000054 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.1 | GO:1990266 | neutrophil migration(GO:1990266) |
0.0 | 0.0 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.7 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.0 | GO:0060087 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.4 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.0 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.0 | 0.0 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.6 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.4 | GO:2000736 | regulation of stem cell differentiation(GO:2000736) |
0.0 | 0.1 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.0 | 0.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.1 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 1.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.0 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.0 | GO:0014857 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.0 | 0.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.2 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) negative regulation of gastrulation(GO:2000542) |
0.0 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.3 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.0 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.1 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.0 | 0.1 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.6 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.0 | 0.0 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 1.4 | GO:0050714 | positive regulation of protein secretion(GO:0050714) |
0.0 | 0.3 | GO:0036503 | ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.0 | 0.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.9 | GO:0051262 | protein tetramerization(GO:0051262) |
0.0 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.0 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.4 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:1901563 | response to camptothecin(GO:1901563) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.0 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.8 | GO:0001666 | response to hypoxia(GO:0001666) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.1 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.0 | 0.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.0 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.0 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
0.0 | 0.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.0 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.5 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.0 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.0 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:0046467 | membrane lipid biosynthetic process(GO:0046467) |
0.0 | 0.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.0 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.0 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0009147 | CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate metabolic process(GO:0009147) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) CTP metabolic process(GO:0046036) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.0 | 0.0 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.0 | 0.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.0 | 0.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.0 | 0.0 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.0 | 0.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.0 | GO:0045191 | regulation of isotype switching(GO:0045191) |
0.0 | 0.0 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.0 | 0.1 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.3 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.0 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.0 | 0.1 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 14.7 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 0.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.0 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.4 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.0 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.0 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.0 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.0 | 0.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.5 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.0 | GO:0002444 | myeloid leukocyte mediated immunity(GO:0002444) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 1.3 | GO:0052547 | regulation of peptidase activity(GO:0052547) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 2.4 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.0 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.0 | 0.0 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.1 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.1 | GO:0009168 | purine nucleoside monophosphate biosynthetic process(GO:0009127) purine ribonucleoside monophosphate biosynthetic process(GO:0009168) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 13.4 | GO:0005638 | lamin filament(GO:0005638) |
2.1 | 6.3 | GO:0035061 | interchromatin granule(GO:0035061) |
2.1 | 8.3 | GO:0070545 | PeBoW complex(GO:0070545) |
1.9 | 16.9 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
1.6 | 6.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.2 | 6.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.2 | 4.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.2 | 3.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.1 | 8.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.1 | 4.4 | GO:0000938 | GARP complex(GO:0000938) |
1.1 | 5.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.0 | 4.0 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.9 | 0.9 | GO:1990745 | EARP complex(GO:1990745) |
0.9 | 3.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.9 | 3.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 3.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.8 | 3.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.8 | 6.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.8 | 2.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.7 | 5.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.7 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.7 | 2.2 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 2.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.7 | 2.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 4.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.6 | 3.2 | GO:0070695 | FHF complex(GO:0070695) |
0.6 | 3.7 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 1.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.6 | 3.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 2.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 2.2 | GO:0071203 | WASH complex(GO:0071203) |
0.6 | 2.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 2.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 0.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 5.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 2.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 1.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 2.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 3.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.5 | 2.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 9.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 2.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 6.8 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 5.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.4 | 4.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 22.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 2.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 1.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 2.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 1.2 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 2.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.4 | 7.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.4 | 1.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 2.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 2.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 5.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 1.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 1.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 1.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.4 | 2.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 2.1 | GO:0005818 | aster(GO:0005818) |
0.4 | 2.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 1.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 3.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 5.7 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 1.3 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 2.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 1.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.8 | GO:0005767 | secondary lysosome(GO:0005767) |
0.3 | 16.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 20.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 5.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 2.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 0.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 1.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 12.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 2.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 0.5 | GO:0044393 | microspike(GO:0044393) |
0.3 | 7.5 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 2.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 24.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 6.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 1.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.3 | 2.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 2.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 1.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.9 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 0.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 3.0 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 4.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.6 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 2.8 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.2 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 2.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 2.8 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 12.9 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 0.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 0.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.2 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 4.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 2.5 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.6 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 1.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 0.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 2.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.9 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 4.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 2.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 6.9 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 4.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 0.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 3.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 3.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 0.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.5 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.2 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.1 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 2.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 2.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 3.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 1.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 2.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 2.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 1.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.9 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 4.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 1.5 | GO:0097517 | stress fiber(GO:0001725) actin filament bundle(GO:0032432) contractile actin filament bundle(GO:0097517) |
0.1 | 4.9 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 8.4 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 9.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 1.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 3.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 4.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 1.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 30.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 2.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 5.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 2.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 11.7 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 1.5 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 1.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 7.4 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 1.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 2.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.1 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 2.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 6.0 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 41.3 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 4.7 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 4.4 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 1.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 5.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 2.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 3.4 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.4 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 3.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 2.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.4 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 105.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 2.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 3.9 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 1.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.0 | GO:0030430 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.0 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.7 | GO:0030135 | coated vesicle(GO:0030135) |
0.0 | 2.0 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 4.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 35.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 6.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 1.0 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.0 | 0.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 4.4 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 1.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 3.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 18.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.9 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 1.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.6 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 1.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 1.4 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.0 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.0 | 0.0 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 6.2 | GO:0005739 | mitochondrion(GO:0005739) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.8 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
2.0 | 6.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
2.0 | 5.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.9 | 15.4 | GO:0008430 | selenium binding(GO:0008430) |
1.9 | 5.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.9 | 9.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.8 | 5.5 | GO:0019961 | interferon binding(GO:0019961) |
1.8 | 1.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.7 | 5.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.6 | 9.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.4 | 19.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.3 | 4.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.2 | 7.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.2 | 5.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.2 | 3.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.1 | 4.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.1 | 3.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.0 | 5.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.0 | 1.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
1.0 | 6.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.0 | 4.0 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.0 | 3.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.0 | 3.9 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.0 | 2.9 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.9 | 2.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.9 | 7.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.9 | 3.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.9 | 3.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.9 | 3.5 | GO:0015265 | urea channel activity(GO:0015265) |
0.9 | 7.8 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.8 | 4.1 | GO:0005534 | galactose binding(GO:0005534) |
0.8 | 2.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.8 | 2.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.7 | 2.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 5.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 3.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.7 | 17.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.7 | 2.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.7 | 2.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.7 | 2.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 3.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 12.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 4.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 3.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.6 | 6.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 21.5 | GO:0043531 | ADP binding(GO:0043531) |
0.6 | 1.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.6 | 2.4 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.6 | 4.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 4.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 4.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 4.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.6 | 2.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 2.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 2.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 7.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 3.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.5 | 4.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 1.9 | GO:0070728 | leucine binding(GO:0070728) |
0.5 | 1.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.5 | 1.4 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 2.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.5 | 0.9 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.5 | 4.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.5 | 1.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 8.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 1.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 5.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 0.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 2.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 1.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 2.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 1.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 3.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.4 | 1.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 1.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 13.5 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 9.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 1.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 7.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 2.9 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 2.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 3.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 1.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.4 | 2.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.4 | 2.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 2.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.4 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 1.6 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 1.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 1.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 1.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 1.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 1.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 1.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 6.4 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.4 | 1.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.4 | 3.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 2.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.4 | 7.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 1.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 1.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.3 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 5.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 12.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 1.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 4.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 1.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 1.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 3.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 0.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 4.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 1.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 5.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 1.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 3.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 0.6 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 5.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 0.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 0.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 1.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 1.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 3.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 8.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 17.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 1.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 7.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 4.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 2.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 1.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.5 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 7.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 1.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 1.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 2.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.9 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.2 | 0.9 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 3.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 2.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 4.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 1.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 3.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 18.3 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 2.2 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.2 | 6.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 1.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 9.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 1.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.9 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 3.4 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 2.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 4.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 3.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 7.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 1.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.8 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 2.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 2.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 1.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 1.7 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.5 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 1.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 2.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 2.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 1.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 2.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 4.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.5 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 3.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 5.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 2.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.5 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 2.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 2.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.8 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 1.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.4 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 3.6 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 2.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 1.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.3 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 13.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.6 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 1.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 5.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 3.3 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) endopeptidase regulator activity(GO:0061135) |
0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 3.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 1.6 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 3.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 1.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 3.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 18.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 1.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 2.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.7 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.1 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 5.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 2.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 3.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 2.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 1.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 1.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 3.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 1.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 1.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 5.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 2.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 2.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 2.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 2.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 1.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 11.5 | GO:0008766 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.1 | 0.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 1.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.6 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.3 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 1.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.2 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 2.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 1.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 2.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.1 | 6.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 3.9 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.1 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 3.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 18.0 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 1.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 2.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 4.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 3.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 11.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 1.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 1.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 11.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 1.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 2.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 6.4 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.2 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 1.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 3.6 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 1.4 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 3.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.9 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 2.9 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 6.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 4.1 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 2.2 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 1.7 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 2.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.0 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.1 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0043492 | phospholipid-translocating ATPase activity(GO:0004012) ATPase activity, coupled to movement of substances(GO:0043492) |
0.0 | 1.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.0 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.0 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 1.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.2 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 1.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.0 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.5 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 14.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.0 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 1.5 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
0.0 | 0.3 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.3 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 7.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.7 | 8.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 16.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.6 | 1.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.5 | 17.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 3.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 17.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 7.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 1.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 18.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 3.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 6.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 6.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 2.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 6.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 6.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 9.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 5.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 3.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 9.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 8.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 6.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 14.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 7.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 1.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 3.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 1.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 0.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 4.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 3.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 0.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 2.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 1.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 1.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 6.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 4.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 1.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 7.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 4.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 25.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 3.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.1 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 5.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 3.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 3.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 3.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 3.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 3.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 4.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 11.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.0 | 9.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 8.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.8 | 15.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.7 | 6.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 5.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.6 | 14.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 3.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 16.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 8.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 2.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.5 | 3.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 5.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 1.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.5 | 14.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 8.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.5 | 9.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.5 | 7.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 3.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.5 | 6.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 4.8 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.4 | 5.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.4 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 5.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 9.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 3.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 15.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 3.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 5.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 3.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 4.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 4.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 1.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 1.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 4.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 5.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.3 | 3.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 2.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 6.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 3.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 3.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 2.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 3.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 3.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 1.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 7.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 10.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 6.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.3 | 16.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 2.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 0.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 5.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 2.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 1.6 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.2 | 2.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 0.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 8.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 7.0 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.2 | 11.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 7.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 3.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 2.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 3.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 6.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 1.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 2.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 3.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 2.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 4.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 6.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 5.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 6.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 2.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 2.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 10.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 2.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 4.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 5.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 3.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 4.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 2.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 8.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 10.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 4.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.5 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.9 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.0 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |